AMLX
Amylyx Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$34.10
+0.41%Leverage
- Debt / equity
- 0.02x
- Net debt / equity
- -0.18x
- Debt / assets
- 0.02x
- Debt / EBITDA
- -0.04x
- Net debt / EBITDA
- 0.29x
Liquidity & coverage
- Current ratio
- 12.12x
- Quick ratio
- 12.12x
- Cash ratio
- 11.86x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- $235.2M
Cash & dividend
- FCF / debt
- -24.11x
- Cash flow / debt
- -24.09x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- -30.0%
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026